WinstonWınston
Stock

M3

MTHRF
62
Medical - Healthcare Information Services · Healthcare
Price
$10.17
-0.19 (-1.86%)
Market Cap
$6.79B
Exchange
Other OTC
Winston Score
62
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Sep 18, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality
Good
Growth
Good
Cash Flow
Weak
Stability
Exceptional
Valuation
Strong
Dividends
Good

§Winston Score History

The full picture

M3, Inc. is a Japanese company that runs online platforms connecting doctors and healthcare professionals. Its flagship site, m3.com, is one of the largest physician communities in the world, with millions of registered doctors across Japan, the US, Europe, and other markets. Pharmaceutical companies use M3's platform to share drug information, conduct market research surveys, and recruit doctors for clinical trials.

M3 makes money primarily by charging pharma and medical device companies for marketing services, physician surveys, and clinical trial support on its platform. It also operates in telemedicine, staffing, and healthcare IT. The massive base of registered physicians gives M3 a strong network effect — the more doctors on the platform, the more valuable it becomes to pharma clients. Key growth drivers include international expansion and AI-powered healthcare services, though the company faces risks from slower pharma marketing spending and increasing competition in digital health markets outside Japan.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+3.8% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

>+1,000% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

¥0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

41.5%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

¥236.2B cash & investments

Quarterly Free Cash Flow

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

M3 is growing revenue at 4% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

0.3% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 679.3M (2022) → 677.2M (2026)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
49.3%
Healthy — 49.3% gross margin
Profit after running costs
Operating Margin
18.5%
Healthy — 18.5% operating margin
Return on the money invested
ROCE
15.5%
Strong — 15.5% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+16.2%
Fast-growing sales (+16.2% YoY)
Profit growth
EPS YoY
+59.8%
Earnings growing fast (+59.8% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
0%
Weak — only 0% of profit becomes cash
Spare cash per sale
FCF Margin
0.0%
Thin free cash flow (0.0%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.09
Conservative — low debt load (0.09)
Covers its interest
Interest Cover
80.84x
Comfortably covers interest (80.8x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
25.8x
Growth-priced — P/E 25.8

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
+7.9
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (25.8 → 17.9)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
1.36%
Small dividend — 1.36% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+46.6%
Dividend growing fast (46.6% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial